Includes image-guided biopsies under mandatory insurance coverage for breast cancer screening.
Summary
Bill A06561 amends the New York insurance law to mandate coverage for image-guided breast biopsies as part of breast cancer screening. This legislation aims to ensure that patients have access to necessary diagnostic procedures recommended by physicians, aligning with nationally recognized clinical practice guidelines. The bill specifies that these guidelines are based on systematic reviews of evidence and assessments of care options, promoting optimal patient care.
Impact
If enacted, this bill will expand the scope of insurance coverage for breast cancer screening in New York, specifically including image-guided biopsies. This change will affect all insurance policies and contracts issued, renewed, or modified after January 1, 2026, ensuring that patients receive comprehensive screening options without additional financial burden. It reinforces the importance of evidence-based practices in healthcare.
Sentiment
The sentiment surrounding Bill A06561 appears to be overwhelmingly positive, as evidenced by the unanimous support in committee votes and final passage in both the Assembly and Senate. The discussions indicate a strong consensus on the necessity of including image-guided biopsies in insurance coverage to enhance breast cancer detection and patient care.
Contention
There are no notable points of contention regarding this bill, as it has received unanimous support throughout the legislative process. The absence of opposing votes suggests a collective agreement on the importance of expanding insurance coverage for breast cancer screening procedures.